propentofylline has been researched along with Disease Exacerbation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mielke, R | 1 |
| Kittner, B | 2 |
| Ghaemi, M | 1 |
| Kessler, J | 1 |
| Szelies, B | 1 |
| Herholz, K | 1 |
| Heiss, WD | 1 |
| De Deyn, PP | 1 |
| Erkinjuntti, T | 1 |
2 trials available for propentofylline and Disease Exacerbation
| Article | Year |
|---|---|
Propentofylline improves regional cerebral glucose metabolism and neuropsychologic performance in vascular dementia.
Topics: Aged; Anti-Ulcer Agents; Cerebral Cortex; Dementia, Vascular; Disease Progression; Female; Glucose; | 1996 |
Investigating the natural course and treatment of vascular dementia and Alzheimer's disease. Parallel study populations in two randomized, placebo-controlled trials.
Topics: Aged; Alzheimer Disease; Cognition; Dementia, Vascular; Disease Progression; Female; Humans; Male; N | 2000 |